The Contorsbody, an antibody format for agonism: Design, structure, and function

Abraham, 2015, GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers, SoftwareX, 1, 19, 10.1016/j.softx.2015.06.001 Atwell, 1997, Stable heterodimer from remodeling the domain interface of a homodimerusing a phage display library, J Mol Biol, 270, 26, 10.1006/jmbi.1997.1116 Bujotzek, 2015, Prediction of VH–VL domain orientation for antibody variable domain modeling, Proteins Struct Funct Bioinf, 83, 681, 10.1002/prot.24756 Brinkmann, 2017, The making of bispecific antibodies, mAbs, 9, 182, 10.1080/19420862.2016.1268307 Biyani, 2017, Focus: the interface between data collection and data processing in cryo-EM, J Struct Biol, 198, 124, 10.1016/j.jsb.2017.03.007 Dassault Systèmes BIOVIA, 2016 Carter, 1992, Humanization of an anti-p185HER2 antibody for human cancer therapy, Proc Natl Acad Sci USA, 89, 4285, 10.1073/pnas.89.10.4285 Chen, 2013, High-resolution noise substitution to measure overfitting and validate resolution in 3D structure determination by single particle electron cryomicroscopy, Ultramicroscopy, 135, 24, 10.1016/j.ultramic.2013.06.004 Chiu, 2019, Antibody structure and function: the basis for engineering therapeutics, Antibodies, 8, 55, 10.3390/antib8040055 Cho, 2003, Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab, Nature, 421, 756, 10.1038/nature01392 Essmann, 1995, A smooth particle mesh Ewald method, J Chem Phys, 103, 8577, 10.1063/1.470117 Evans, 1985, The nose–hoover thermostat, J Chem Phys, 83, 4069, 10.1063/1.449071 Hess, 1997, LINCS: a linear constraint solver for molecular simulations, J Comput Chem, 18, 1463, 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H Jorgensen, 1983, Comparison of simple potential functions for simulating liquid water, J Chem Phys, 79, 926, 10.1063/1.445869 Kaplon, 2020, Antibodies to watch in 2020, MAbs, 12, 1703531, 10.1080/19420862.2019.1703531 Kaplon, 2019, Antibodies to watch in 2019, MAbs, 11, 219, 10.1080/19420862.2018.1556465 Le Basle, 2020, Physicochemical stability of monoclonal antibodies: a review, J Pharm Sci, 109, 169, 10.1016/j.xphs.2019.08.009 Leavy, 2010, Therapeutic antibodies: past, present and future, Nat Rev Immunol, 10 Lindorff-Larsen, 2010, Improved side-chain torsion potentials for the Amber ff99SB protein force field, Proteins Struct Funct Bioinf, 78, 1950, 10.1002/prot.22711 Ludtke, 1999, EMAN: semiautomated software for high-resolution single-particle reconstructions, J Struct Biol, 128, 82, 10.1006/jsbi.1999.4174 Ma, 2019, Unravelling enhancement of antibody fragment stability – role of format structure and cysteine modification, J Immunol Methods, 464, 57, 10.1016/j.jim.2018.10.012 Marmor, 2004, Signal transduction and oncogenesis by ErbB/HER receptors, Int J Radiat Oncol Biol Phys, 58, 903, 10.1016/j.ijrobp.2003.06.002 Mastronarde, 2005, Automated electron microscope tomography using robust prediction of specimen movements, J Struct Biol, 152, 36, 10.1016/j.jsb.2005.07.007 Mayes, 2018, The promise and challenges of immune agonist antibody development in cancer, Nat Rev Drug Discov, 17, 509, 10.1038/nrd.2018.75 Melchionna, 1993, Hoover NPT dynamics for systems varying in shape and size, Mol Phys, 78, 533, 10.1080/00268979300100371 Mijares, 2000, From agonist to antagonist: Fab fragments of an agonist-like monoclonal anti-beta(2)-adrenoceptor antibody behave as antagonists, Mol Pharmacol, 58, 373, 10.1124/mol.58.2.373 Natha, 2006, Herceptin: mechanisms of action and resistance, Cancer Lett, 232, 123, 10.1016/j.canlet.2005.01.041 Oganesyan, 2014, Structural insights into neonatal fc receptor-based recycling mechanisms, J Biol Chem, 289, 7812, 10.1074/jbc.M113.537563 Olayioye, 2001, Intracellular signaling pathways of ErbB2/HER-2 and family members, Breast Cancer Res, 3, 385, 10.1186/bcr327 Reichert, 2017, Antibodies to watch in 2017, mAbs, 9, 167, 10.1080/19420862.2016.1269580 Remesh, 2018, Conformational plasticity of the immunoglobulin fc domain in solution, Structure, 26, 1007, 10.1016/j.str.2018.03.017 Ries, 2014, Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy, Cancer Cell, 25, 46, 10.1016/j.ccr.2014.05.016 Rosenthal, 2003, Optimal determination of particle orientation, absolute hand, and contrast loss in single-particle electron cryomicroscopy, J Mol Biol, 333, 721, 10.1016/j.jmb.2003.07.013 Sakae, 2017, Conformational effects of N-glycan core fucosylation of immunoglobulin G Fc region on its interaction with Fcγ receptor IIIa, Sci Rep, 7, 13780, 10.1038/s41598-017-13845-8 Saphire, 2001, Crystal structure of a neutralizing human IgG against HIV-1: a template for vaccine design, Science, 293, 1155, 10.1126/science.1061692 Scheer, 2012, Reorienting the fab domains of trastuzumab results in potent HER2 activators, PLoS One, 7, 51817, 10.1371/journal.pone.0051817 Scheres, 2012, RELION: implementation of a Bayesian approach to cryo-EM structure determination, J Struct Biol, 180, 519, 10.1016/j.jsb.2012.09.006 Shi, 2018, A biparatopic agonistic antibody that mimics fibroblast growth factor 21 ligand activity, J Biol Chem, 293, 5909, 10.1074/jbc.RA118.001752 Sliwkowski, 2013, Antibody therapeutics in cancer, Science, 341, 1192, 10.1126/science.1241145 Valabrega, 2007, Trastuzumab: mechanism of action, resistance and future perspectives in HER2-overexpressing breast cancer, Ann Oncol, 18, 977, 10.1093/annonc/mdl475 Vonderheide, 2020, CD40 agonist antibodies in cancer immunotherapy, Annu Rev Med, 71, 1.1, 10.1146/annurev-med-062518-045435 Vu, 2012, Trastuzumab: updated mechanisms of action and resistance in breast cancer, Front Oncol, 2, 62, 10.3389/fonc.2012.00062 Wang, 2007, Antibody structure, instability, and formulation, J Pharm Sci, 96, 1, 10.1002/jps.20727 White Jay, 2018, IgG antibody 3D structures and dynamics, Antibodies, 7, 18, 10.3390/antib7020018 Yageta, 2019, CH2 domain orientation of human immunoglobulin G in solution: structural comparison of glycosylated and aglycosylated Fc regions using small-angle X-ray scattering, mAbs, 11, 453, 10.1080/19420862.2018.1546086 Yanga, 2019, Tetravalent biepitopic targeting enables intrinsic antibody agonism of tumor necrosis factor receptor superfamily members, mAbs, 11, 996, 10.1080/19420862.2019.1625662 Zhang, 2016, Gctf: real-time CTF determination and correction, J Struct Biol, 193, 1, 10.1016/j.jsb.2015.11.003 Zhang, 2015, 3D Structural fluctuation of IgG1 revealed by individual particle Electron Tomography, Sci Rep, 5, 9803, 10.1038/srep09803